This activity is supported by an educational grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.
NPs and PAs specializing in rheumatology
Upon completion of this activity, participants should be able to:
Identify appropriate uses of new and emerging agents for patients with PsA
Create treatment plans for patients with PsA based on current guidelines, patient disease course, and patient preferences
Apply up-to-date methods for assessment and management of comorbidities and dermatologic manifestations of psoriatic disease
All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Shannon Ghizzoni, PA-C: consultant/advisor/speaker: AbbVie, Amgen, Novartis.
Elaine Husni, MD, MPH: consultant/advisor/speaker: AbbVie, Amgen, Bristol-Myers Squibb, Janssen, Lilly, Novartis, Pfizer, UCB.
Joan McTigue, MS, PA-C, has no relevant financial relationships to disclose.
Jennifer Simpson, DNP: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, Horizon, Janssen.
None of the members of the Planning Committee, PACE or PCE staff have any relevant financial relationships to disclose, except Jennifer Simpson, DNP, as noted above.
Learners wishing to earn CE/CME credit must:
The estimated time to complete this activity is 1.00 hour.
Release date: October 20, 2022
Expiration date: October 19, 2023
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange, Partners for Advancing Clinical Education, or any educational supporter.
Joint Accreditation Statement
In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP course advisor: Jennifer Simpson, DNP, Arizona Arthritis and Rheumatology Associates, Phoenix, Arizona
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until October 19, 2023. PAs should only claim credit commensurate with the extent of their participation.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program has been made available online.